Prime Therapeutics Launches New Pharmacy Offering

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans.

Prime Therapeutics’ synergy with the Blues allows it to develop market-leading products and services that reflect shared goals of safety, quality and cost-savings. Prime Therapeutics, implementing a strategy, as a number of brands are to lose patent protection, recently launched four new benefits packages offering a complete spectrum of options from rich benefits to deep savings. One of the new plans, Reliance, comes with a net drug spend guarantee of $47 per prescription.

Reliance includes a four-tier generics-focused formulary, access to drugs through PrimeMail® and a national network of retail pharmacies and utilization management programs aimed at improving patient safety and encouraging use of effective lower cost medications. By taking advantage of recommended benefit options, Reliance will encourage adoption of behaviors that help keep individuals healthy and hold down costs.

Prime is also releasing three additional benefits packages: Essential, Keystone and Premier. For plan sponsors in need of even greater pharmacy savings, the Essential offering provides the greatest cost savings by encouraging mail service delivery and generic medications. The Keystone and Premier options will offer a wider range of pharmacy options and medication choices, but at higher costs than the other two options provide.